Vivos Therapeutics, Inc. (VVOS)
0.8424
-0.05
(-5.97%)
USD |
NASDAQ |
Apr 24, 16:00
0.8422
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Profit Margin (Quarterly) : -181.9% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -- |
| Celldex Therapeutics, Inc. | -67.20K% |
| Plus Therapeutics, Inc. | -417.9% |
| Atossa Therapeutics, Inc. | -- |
| Abeona Therapeutics, Inc. | -377.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -592.2% |
| Return on Assets | -102.7% |
| Return on Invested Capital | -181.7% |
| Gross Profit Margin (Quarterly) | 66.58% |
| Operating Margin (Quarterly) | -166.9% |
| Return on Net Operating Assets | -127.0% |